The transdermal fentanyl therapy patch Matrifen® eases your pain

The transdermal fentanyl therapy patch Matrifen® from Nycomed provides pain relief for patients with severe chronic pain.

With the transdermal fentanyl therapy patch Matrifen® you can ease severe chronic pain in patientes with cancer.

>> Information on the transdermal fentanyl therapy patch Matrifen®

Matrifen® is a transdermal fentanyl therapy patch with membrane controlled release. It is a 72 hour or 3 day patch with a skin friendly silicone adhesion layer, that sticks well to the surface of the skin.

The efficient and advanced transdermal fentanyl therapy patch technology provides pain relief for cancer related as well as non cancer related pains and the lower drug load adds to a higher degree of safety and lower environmental burden.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Skin friendly silicone layer | Transdermal application | Silicone adhesion layer